Income Statement (OBALON/THERAPEUTICS)

Technical Analysis Historical Data Financials News & Analysis

OBALON/THERAPEUTICS NEWS

ReShape Lifesciences® Announces Strategic Cost Reductions and Provides Update on the Merger Agreement with Vyome Therapeutics and Asset Purchase Agreement with Biorad Medisys By ReShape - 1 week ago

Reduction in Force Estimated to Save Over $750K or 23.4% of Annual Payroll Expenses Agreements Progress Toward Completion; Shareholder Meeting Scheduled for July 24, 2025 IRVINE, Calif., June 26, 2… [+9315 chars]...

Read more
Top Stock
CurrencyPrice Chg
BA 		226.52 8
3.66%
CVX 		153.02 -0.22
-0.14%
CAT 		402.29 8
2.03%
INTC 		23.44 -0.15
-0.64%
MSFT 		503.51 6.89
1.39%
DIS 		120.61 -1.21
-0.99%
DOW 		29.84 0.78
2.67%
CSCO 		69.27 0.68
0.99%
GS 		696.56 -0.72
-0.1%